Emotion and Symptom-focused Engagement for Caregivers (EASE-CG) Pilot Study
EASE-CG
Pilot Study of a Novel Psychotherapeutic Intervention for Caregivers of Patients With Acute Leukemia: Emotion and Symptom-focused Engagement for Caregivers (EASE-CG)
1 other identifier
interventional
40
1 country
2
Brief Summary
The purpose of this study is to test the feasibility and acceptability of an adapted psychosocial intervention, called Emotion and Symptom-focused Engagement for Caregivers (EASE-CG), to reduce traumatic stress symptoms and other psychological distress and increase well-being in primary caregivers of patients newly diagnosed with acute leukemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2022
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2022
CompletedFirst Posted
Study publicly available on registry
February 11, 2022
CompletedStudy Start
First participant enrolled
April 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJuly 17, 2025
July 1, 2025
2.7 years
February 1, 2022
July 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Stanford Acute Stress Reaction Questionnaire (SASRQ-II)
A 30-item reliable, valid, and widely used self-report measure assessing the severity of traumatic stress symptoms over the past four weeks. Total SASRQ scores may range from 0-150, with higher scores indicating increasingly severe traumatic stress symptoms. This measure has been updated to be Diagnostic and Statistical Manual of Mental Disorders (DSM-5)-concordant for acute stress disorder symptoms.
12 weeks
PTSD Checklist for DSM-5 (PCL-5)
A 20-item reliable and valid self-report measure of the presence and severity of post-traumatic stress disorder (PTSD) symptoms over the past month. Total PCL-5 scores may range from 0-80, with higher scores indicating increasingly severe PTSD symptoms. This DSM-5-concordant measure has been included to help validate the DSM-5-concordant version of the SASRQ.
12 weeks
Secondary Outcomes (6)
Brief Experiences in Close Relationships Scale (ECR-M16)
12 weeks
Patient Health Questionnaire-9 (PHQ-9)
12 weeks
Caregiver Reaction Assessment (CRA) Scale
12 weeks
Enhancing Recovery In Coronary Heart Disease (ENRICHD) Social Support Inventory (ESSI)
12 weeks
Family Satisfaction with End-of-Life Care (FAMCARE) Scale
12 weeks
- +1 more secondary outcomes
Study Arms (1)
EASE-CG Intervention
EXPERIMENTALParticipants will be offered one EASE-CG therapy session every week for up to 12 weeks. Each session will last for approximately 30-60 minutes, delivered by a trained therapist at our center. Frequency and/or length of sessions may vary to accommodate the needs and availability of each participant. Outcomes will be assessed at baseline, 1, 3, 6, 9, and 12 months. Participants may be invited to brief, semi-structured interviews.
Interventions
EASE-CG is an adapted brief psychotherapeutic intervention with relational support and trauma-based cognitive behavioral therapy (CBT) components.
Eligibility Criteria
You may qualify if:
- Self-identified primary caregiver (i.e., person assuming the majority of care activities) or co-primary caregiver (i.e., assuming at least 40% of care activities alongside another co-primary caregiver) of an adult or pediatric patient who is newly diagnosed with acute leukemia within 3 months of admission to the Princess Margaret Cancer Centre or the Hospital for Sick Children
- Age ≥18 years
- Fluency in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Health Network, Torontolead
- The Hospital for Sick Childrencollaborator
Study Sites (2)
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
Related Publications (2)
Rodin G, Malfitano C, Rydall A, Schimmer A, Marmar CM, Mah K, Lo C, Nissim R, Zimmermann C. Emotion And Symptom-focused Engagement (EASE): a randomized phase II trial of an integrated psychological and palliative care intervention for patients with acute leukemia. Support Care Cancer. 2020 Jan;28(1):163-176. doi: 10.1007/s00520-019-04723-2. Epub 2019 Apr 17.
PMID: 31001692BACKGROUNDJibb LA, Yu A, Nanos S, Malfitano C, Foran L, Hunt K, Malakian A, Zimmermann C, Schultebraucks K, Pham NA, Rydall A, Alexander S, Rodin G. The Emotion and Symptom-Focused Engagement (EASE) Psychotherapeutic Intervention for Parents of Children With Acute Leukemia: A Feasibility Trial. Psychooncology. 2025 Nov;34(11):e70310. doi: 10.1002/pon.70310.
PMID: 41161769DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gary Rodin, MD FRCPC
University Health Network, Toronto
- PRINCIPAL INVESTIGATOR
Lindsay Jibb, RN PhD
The Hospital for Sick Children
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2022
First Posted
February 11, 2022
Study Start
April 12, 2022
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
July 17, 2025
Record last verified: 2025-07